期刊文献+

糖尿病与非糖尿病维持性血液透析患者25-羟-维生素D水平的差异及影响因素分析 被引量:2

Differences and influent factors of serum levels of 25-hydroxy-vitamin D between maintenance hemodialysis patients with diabetes and non-diabetes
暂未订购
导出
摘要 目的探讨糖尿病与非糖尿病维持性血液透析(maintenance hemodialysis,MHD)患者体内25-羟-维生素D水平的差异及影响因素。方法纳入四川省肾血液净化中心135例维持性血液透析患者,其中糖尿病41例(糖尿病组),非糖尿病94例(非糖尿病组),收集一般资料,检测血25-羟-维生素D水平、血生化、血常规及甲状旁腺激素(iPTH)。采用脉搏波传导速度及踝肱指数评价血管病变;比较糖尿病与非糖尿病组血25-羟-维生素D水平的差异。以25-羟-维生素D水平小于30ng/ml为降低标准,采用多因素Logistic回归分析法分析维生素D水平下降的影响因素。结果与非糖尿病组相比,糖尿病组患者透析前血肌酐水平较低,25-羟-维生素D水平较低;多元回归分析提示较高的iPTH水平、临床给予维生素D治疗的患者以及糖尿病为维生素D下降的独立危险因素。结论糖尿病维持性透析患者较非糖尿病MHD患者有较高的维生素D不足的风险,应重视该人群维生素D不足的治疗。 Objective To investigate the difference and influent factors of serum levels 25-hydroxy-vitamin D(25-OH-VD)be- tween maintenance hemodialysis patients with diabetics and non-diabetics. Methods One hundred and thirty-five maintenance hemodi- alysis (MHD) patients, in which 41 were diabetics and 94 were non-diabetics, were enrolled. The general information was collected. Se- rum 25-OH-VD, serum biochemistry,whole blood cell count and iPTH were determined. Pulse wave velocity and ankle-brachial index was applied to evaluate vascular disease. Difference in serum 25-OH-VD levels was compared between diabetic and non-diabetic MHD patients,and multiple logistic regressions was applied to study risk factors of Vit D deficiency. Results Serum creatinine and 25-OH- VD was lower in diabetic MHD patients than that in non-diabetic patients. Multiple logistic regressions showed that higher iPTH, patients received vitamin D therapy and diabetes were independently associated with 25-OH-VD deficiency. ConclusiOns Diabetic MHD patients are more likely to have serum 25-OH-VD deficiency than non-diabetic MHD patients. More attention should be paid on treat- ment vitamin D deficiency in these patients.
出处 《实用医院临床杂志》 2013年第4期50-52,共3页 Practical Journal of Clinical Medicine
关键词 糖尿病 血液透析 25羟-维生素D Diabetes Hemodialysis 25-hydroxy-vitamin D
  • 相关文献

参考文献21

  • 1Pilz S,Tomaschitz A, Friedl C, et al. Vitamin D status and mortality in chronic kidney disease [ J ]. Nephrol Dial Transplant, 2011,26 ( 11 ) :3603-3609.
  • 2Querfeld U, Mak RH. Vitamin D deficiency and toxicity in chronic kidney disease : in search of the therapeutic window [ J ]. Pediatr Nephrol,2010,25 (12) :2413-2430.
  • 3Janner M, Ballinari P, Mullis PE, et al. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes [ J ]. SwissMed Wkly,2010,140 : w13091.
  • 4Velayoudom-Cephise FL, Larifla L, Donnet JP, et al. Vitamin D defi- ciency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes [ J ]. Diabetes Metab, 2011,37 ( 6 ) :540-545.
  • 5王莉,洪大情,王政通,王君如,刘章锁.糖尿病与非糖尿病维持性血液透析患者血管钙化的对比研究[J].临床肾脏病杂志,2011,11(5):210-212. 被引量:2
  • 6洪大情,何强,王君如,卢雨润,蒲蕾,张月,吴姝焜,高辉,李贵森,王莉.X线平片、脉搏波传导速度及踝肱指数在维持性血液透析患者血管钙化评价中的应用[J].肾脏病与透析肾移植杂志,2012,21(4):335-340. 被引量:6
  • 7Reichel H, Deibert B, Schmidt-Gayk H, et al. Calcium metabolism in early chronic renal failure : implications for the pathogenesis of hyper- parathyroidism [ J]. Nephrol Dial Transplant, 1991,6 ( 3 ) : 162-169.
  • 8Tessitore N, Venturi A, Adami S, et al. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure[ J]. Miner Electrolyte Metab, 1987,13 ( 1 ) : 38-44.
  • 9于媛,王宓,王梅.慢性肾脏病3~5期非透析患者25(OH)D与1,25(OH)_2D水平的相关性及影响因素[J].中国血液净化,2011,10(6):310-314. 被引量:25
  • 10Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease [ J ]. Kidney Int, 2009,75 ( 1 ) : 88-95.

二级参考文献79

  • 1Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis, 2003,41 : 11-17.
  • 2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000,342:1478-1483.
  • 3Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002, 39: 695-701.
  • 4Bellasi A, Ferrarnosca E, Muntner P,et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int,2006,70:1623- 1628.
  • 5Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hernodialysis patients. Am J Kidney Dis, 2007,49:417-425.
  • 6KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, 2009, 113: S1-130.
  • 7Leskinen Y, Paana T, Saha H, et al Valvular calcification and its relationship to atheroselerosis in chronic kidney disease. J Heart Valve Dis,2009,18:429-438.
  • 8Chertow GM, Raggi P, Chasan-Taber S, et alDeterminants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant, 2004,19:1489-1496.
  • 9Qunibi WY. Cardiovascular calcification in nondialyzed patients with chronic kidney disease. Semin Dial, 2007,20:134-138.
  • 10Ishimura E, Okuno S, Taniwaki H, et al. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: The respective importance of glycemic and phosphate control. Kidney Blood Press Res, 2008,31 : 10-15.

共引文献39

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部